Intestinal Disease Education and Awareness Society IDEAS -
QBECO Crohns Disease Clinical Trial., Qu Biologics’ proprietary Site Specific Immunomodulators (SSIs) are investigational treatments containing preparation of a single species of killed bacteria that were developed to stimulate the innate immune system in a tissue and/or organ specific manner, to reverse the chronic inflammation underlying many conditions including cancer, arthritis, and inflammatory bowel disease. […]
The post QBECO Crohns Disease Clinical Trial appeared first on Intestinal Disease Education and Awareness Society IDEAS.